Submit your email address to sign up for the Visionary,
or monthly newsletter.

X

Search the Radiation Oncology Institute

X

Submit your email address to sign up for the Visionary,
or monthly newsletter.

X

Search the Radiation Oncology Institute

X
Close Index

The Visionary (Spring 2022, Vol. 12, No. 1)

Annual ROI Publication Award Nominations Now Open
Recognize an early career researcher for their outstanding work on a recent manuscript.
ROI Researcher Honored for Work on Financial Toxicity
Fumiko Chino, MD, appreciates how ROI funding played a role in her success.
Join Our Team: Become a President’s Circle Donor!
Join our important work by making a donation to the Radiation Oncology Institute!
Library of eContouring Webinars Grows
Watch replays of two recent webinars on cardiac radioablation for ventricular tachycardia and hematologic malignancies.
Springing Into Action
ROI President Colleen A.F. Lawton, MD, FASTRO, shares how ROI research is flourishing.
Issue Index

ROI Researcher Honored for Work on Financial Toxicity

The Radiation Oncology Institute (ROI) congratulates Fumiko Chino, MD, on her recent selection as the inaugural winner of the ASCO Excellence in Equity Award. She is receiving the award for her commitment to increasing access to equitable care for cancer patients. Dr. Chino’s research focuses on patient-reported outcomes, health equity, and improving affordability of cancer care. She is a pioneer in “financial toxicity” research, leading some of the first studies in this area specific to radiation therapy.
 
As a resident at Duke University, Dr. Chino won an ROI Innovative Projects in Radiation Oncology Award to conduct a prospective study of patient reported outcomes and financial toxicity for patients with head and neck cancer receiving radiation therapy. She was mentored by Yvonne Mowery, MD, PhD, and David Brizel, MD. This study is the first to collect actual out-of-pocket cost data for patients receiving radiation. Dr. Chino presented baseline data from the study at the 2021 ASCO Quality Care Symposium showing that one-third of patients had already made significant financial sacrifices before radiation had even started; additional presentations and publications are forthcoming.
 
"I was honored to receive the 2022 ASCO Excellence in Equity award, and I know that ROI is partially responsible. ROI's investment in my research in financial toxicity allowed me to flourish as a young investigator. The grant support I received as a resident was instrumental to my career and was the foundation I used to build my current research," says Dr. Chino. She is continuing her research and advocacy for patients as an attending physician at Memorial Sloan Kettering Cancer Center.
 
Dr. Chino will be recognized with the Excellence in Equity Award at the 2022 ASCO Annual Meeting in Chicago in June. ROI is proud to have supported Dr. Chino’s ground-breaking research on financial toxicity and looks forward to her lasting success in improving outcomes for patients with cancer.
 
The ROI is ASTRO’s research foundation, dedicated to advancing the lifesaving and quality-of-life benefits of radiation therapy. The work of ROI is made possible thanks to the generosity of our donors.